- Home
- KZIA vs BCIC Comparison
KZIA vs BCIC Comparison
Compare KZIA & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KZIA | BCIC |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | Australia | United States |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 96.9M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | KZIA | BCIC |
|---|---|---|
| Price | $13.59 | $8.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $19.50 | $9.00 |
| AVG Volume (30 Days) | ★ 272.9K | 89.4K |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.05 | $7.11 |
| 52 Week High | $17.40 | $13.50 |
Technical Indicators
Market Signals| Indicator | KZIA | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 74.57 | 47.78 |
| Support Level | $5.85 | $7.75 |
| Resistance Level | $14.42 | $8.13 |
| Average True Range (ATR) | 1.32 | 0.17 |
| MACD | 0.23 | 0.08 |
| Stochastic Oscillator | 84.64 | 48.25 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.